Tangible Shareholders Equity (Quarterly)

Tangible Shareholders Equity: The value shareholders equity less intangible assets.

Citius Pharmaceuticals, Inc. (CTXR) had Tangible Shareholders Equity of $66.56M for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$1.49M
Net Income	$-8.86M
Cost of Goods Sold	$0.49M
Gross Profit	$1.00M
Operating Expenses	$13.23M
Operating Income	$-11.73M
Non-Operating Income/Expense	$-0.29M
Pre-Tax Income	$-12.03M
Normalized Pre-Tax Income	$-12.03M
Income after Taxes	$-11.92M
Income from Continuous Operations	$-11.92M
Consolidated Net Income/Loss	$-11.92M
Normalized Income after Taxes	$-11.92M
EBIT	$-11.73M
EBITDA	$-9.79M
Weighted-Average Shares Outstanding (Basic)	26.17M
Weighted-Average Shares Outstanding (Diluted)	26.17M
Earnings per Share (EPS) (Basic)	$-0.34
Earnings per Share (EPS) (Diluted)	$-0.34
Balance Sheet Financials
Current Assets	$43.33M
Property, Plant, and Equipment	--
Long-Term Assets	$98.92M
Total Assets	$142.26M
Current Liabilities	$51.65M
Long-Term Debt	$6.41M
Long-Term Liabilities	$14.70M
Total Liabilities	$66.35M
Common Equity	$75.91M
Tangible Shareholders Equity	$66.56M
Shareholders Equity	$75.91M
Common Shares Outstanding	27.45M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-22.99M
Cash Flow from Investing Activities	$-7.00M
Cash Flow from Financial Activities	$42.74M
Beginning Cash	$4.25M
End Cash	$17.01M
Increase/Decrease in Cash	$12.76M
Stock-Based Compensation	$11.88M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.84
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.08
Debt to Equity Ratio	0.08
Gross Margin	67.07%
Operating Margin	-785.39%
EBIT Margin	-785.39%
EBITDA Margin	--
Pre-Tax Profit Margin	-805.11%
Profit Margin	-593.31%
Free Cash Flow	$-22.99M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.01
Inventory Turnover	0.02
Receiveable Turnover	2.18
Days Sales in Receivables	41.35
Return on Equity	-15.70%
Return on Tangible Equity	-17.91%
Return on Assets	-8.38%
Return on Investments	-14.48%
Book Value Per Share	$2.77
Free Cash Flow per Share	$-0.88
Operating Cash Flow per Share	$-0.88

Data from Zacks Investment Research, Inc.